Back
Sequans Communications SA Vs. Aligos Therapeutics Industry Stock Comparison
Buy
64
SQNS
Sequans Communications SA
Last Price:
$3.52
Seasonality Move:
3.51%
Buy
69
ALGS
Aligos Therapeutics
Last Price:
$43.48
Seasonality Move:
-17.17%
Buy
64
Sequans Communications SA (SQNS)
is a Buy
Is Sequans Communications SA a Buy, Sell or Hold?
-
The current Sequans Communications SA [SQNS] share price is $3.43. The Score for SQNS is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
-
SQNS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
69
Aligos Therapeutics (ALGS)
is a Buy
Is Aligos Therapeutics a Buy, Sell or Hold?
-
The current Aligos Therapeutics [ALGS] share price is $43.42. The Score for ALGS is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.
-
ALGS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
SQNS Stock Price Chart
What is Sequans Communications SA's stock price today?
-
The Sequans Communications SA share price today is $3.43Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SQNS is experiencing slight selling pressure.
ALGS Stock Price Chart
What is Aligos Therapeutics's stock price today?
-
The Aligos Therapeutics share price today is $43.42Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALGS is experiencing buying pressure, which is a positive indicator for future bullish movement.
SQNS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.15 | Buy |
Relative Strength Index (14 RSI): | 63.52 | Buy |
Chaikin Money Flow: | -30918 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.93 - 3.37) | Buy |
Bollinger Bands (100): | (2.14 - 3.1) | Buy |
ALGS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 5.14 | Buy |
Relative Strength Index (14 RSI): | 74.33 | Buy |
Chaikin Money Flow: | 210748 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (27.82 - 40.1) | Buy |
Bollinger Bands (100): | (6.77 - 28.07) | Buy |
SQNS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 3.33 | Buy |
20-day SMA: | 3.14 | Buy |
50-day SMA: | 2.88 | Buy |
200-day SMA: | 1.98 | Buy |
8-day EMA: | 3.33 | Buy |
20-day EMA: | 3.17 | Buy |
50-day EMA: | 2.93 | Buy |
200-day EMA: | 2.86 | Buy |
ALGS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 40.78 | Buy |
20-day SMA: | 36.11 | Buy |
50-day SMA: | 23.97 | Buy |
200-day SMA: | 16.97 | Buy |
8-day EMA: | 40.32 | Buy |
20-day EMA: | 35.95 | Buy |
50-day EMA: | 27.43 | Buy |
200-day EMA: | 19.22 | Buy |
Sequans Communications SA Earnings Growth & SQNS Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, a decrease this year of $3.01 per share, and a decrease next year of $0.00 per share.
Aligos Therapeutics Earnings Growth & ALGS Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $2.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $2.65 per share, and a decrease next year of $0.14 per share.
Sequans Communications SA Technical Analysis
Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
19 | 20 | 23 | 24 | 26 | 27 | 30 | 31 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Aligos Therapeutics Technical Analysis
Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
19 | 20 | 23 | 24 | 26 | 27 | 30 | 31 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |